Video

Dr. Campbell on the Future of the Management of RCC

Steven Campbell, MD, PhD, urologist, Cleveland Clinic, discusses the future of the treatment management for patients with renal cell carcinoma (RCC).

Steven Campbell, MD, PhD, urologist, Cleveland Clinic, discusses the future of the treatment management for patients with renal cell carcinoma (RCC).

In the future, researchers hope to see an increased utilization of partial nephrectomy and a more sensible utilization of radical nephrectomy, states Campbell.

Many are advocating for a utility-based approach to renal mass biopsy, meaning it will only be applied to patients who might have their treatment management changed, explains Campbell.

Related Videos
Minoo Battiwalla, MD, MS
Cynthia X. Ma, MD, PhD
Jyoti Patel, MD
Leo I. Gordon, MD
Bertram Yuh, MD, MISM, MSHCPM
Alexander Drilon, MD
David Rimm, MD, PhD
Laahn Ho Foster, MD
David C. Fisher, MD
Michel Ducreux, MD, PhD, head, Gastrointestinal Oncology Unit, head, Gastrointestinal Oncology Tumor Board, Gustave Roussy; professor, oncology, Paris-Saclay University